Bridgeway Capital Management LLC Decreases Stock Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Bridgeway Capital Management LLC trimmed its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 5.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 193,500 shares of the company’s stock after selling 11,200 shares during the quarter. Bridgeway Capital Management LLC owned about 0.23% of Stereotaxis worth $441,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of STXS. Jane Street Group LLC boosted its position in shares of Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after acquiring an additional 6,313 shares during the last quarter. SG Americas Securities LLC grew its position in Stereotaxis by 39.2% in the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after acquiring an additional 7,417 shares during the period. Geode Capital Management LLC grew its position in Stereotaxis by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 1,399,498 shares of the company’s stock worth $3,192,000 after acquiring an additional 7,780 shares during the period. Wealth Effects LLC grew its position in Stereotaxis by 11.7% in the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after acquiring an additional 9,000 shares during the period. Finally, Wells Fargo & Company MN grew its position in Stereotaxis by 53.7% in the fourth quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock worth $61,000 after acquiring an additional 9,403 shares during the period. 45.35% of the stock is owned by hedge funds and other institutional investors.

Stereotaxis Price Performance

Shares of STXS opened at $2.13 on Monday. Stereotaxis, Inc. has a 1-year low of $1.54 and a 1-year high of $2.72. The stock has a market cap of $180.47 million, a PE ratio of -7.61 and a beta of 1.54. The firm has a 50-day simple moving average of $1.88 and a two-hundred day simple moving average of $2.07.

Insider Activity at Stereotaxis

In other Stereotaxis news, Director Paul J. Isaac bought 38,000 shares of Stereotaxis stock in a transaction on Monday, March 10th. The shares were bought at an average cost of $1.81 per share, for a total transaction of $68,780.00. Following the acquisition, the director now directly owns 87,299 shares in the company, valued at $158,011.19. This represents a 77.08% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 18.52% of the company’s stock.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.